Page last updated: 2024-12-06

allomaltol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Allomaltol, a furan derivative, is a naturally occurring compound found in various plant species and has been studied for its potential applications in several fields. It is known to possess antioxidant, antimicrobial, and anti-inflammatory properties. Its synthesis has been achieved through various chemical methods, including the dehydration of D-glucose and the pyrolysis of cellulose. Researchers are exploring the potential of allomaltol as a therapeutic agent for treating a range of diseases, including cancer and diabetes, due to its ability to modulate cellular signaling pathways and inhibit the growth of tumor cells. Furthermore, allomaltol has shown promising results as a food preservative and flavor enhancer, making it an attractive alternative to synthetic chemicals. The study of allomaltol continues to be driven by its diverse biological activities and potential for development in various industries.'

allomaltol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID69521
CHEMBL ID119083
SCHEMBL ID4649390
SCHEMBL ID791161
MeSH IDM0547590

Synonyms (35)

Synonym
644-46-2
4h-pyran-4-one, 5-hydroxy-2-methyl-
kojic acid, .alpha.-deoxy-
nsc166902
nsc-166902
5-hydroxy-2-methyl-.gamma.-pyrone
allomaltol
CHEMBL119083 ,
5-hydroxy-2-methylpyran-4-one
FT-0661489
AKOS006293931
5-hydroxy-2-methyl-4h-pyran-4-one
a3l2726a8x ,
unii-a3l2726a8x
nsc 166902
2-methyl-5-hydroxy-(4h)-pyran-4-one
allo maltol
6X-0801
SCHEMBL4649390
5-hydroxy-2-methyl-4-pyrone
SCHEMBL791161
BBL034899
STL426078
DTXSID70214652
mfcd04125897
5-hydroxy-2-methyl-4h-pyran-4-one, aldrichcpr
BCP25542
5-hydroxy-2-methyl-4h-pyran-4-one;allomaltol
EN300-139613
E78575
Q27273574
A914112
bdbm50536113
SY153564
Z1198164652
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polymerase acidic proteinInfluenza A virus (A/Puerto Rico/8/1934(H1N1))IC50 (µMol)16.47451.88004.68805.8600AID1635903
Cytochrome P450 2C19Homo sapiens (human)IC50 (µMol)16.47450.00002.398310.0000AID1635903
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (7)

Processvia Protein(s)Taxonomy
long-chain fatty acid metabolic processCytochrome P450 2C19Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C19Homo sapiens (human)
steroid metabolic processCytochrome P450 2C19Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C19Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C19Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C19Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C19Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (14)

Processvia Protein(s)Taxonomy
monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
iron ion bindingCytochrome P450 2C19Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C19Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C19Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
oxygen bindingCytochrome P450 2C19Homo sapiens (human)
enzyme bindingCytochrome P450 2C19Homo sapiens (human)
heme bindingCytochrome P450 2C19Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
aromatase activityCytochrome P450 2C19Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 2C19Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C19Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C19Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
extracellular regionPolymerase acidic proteinInfluenza A virus (A/Puerto Rico/8/1934(H1N1))
endoplasmic reticulum membraneCytochrome P450 2C19Homo sapiens (human)
plasma membraneCytochrome P450 2C19Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C19Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C19Homo sapiens (human)
cytoplasmCytochrome P450 2C19Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (26)

Assay IDTitleYearJournalArticle
AID397011Antifungal activity against Candida albicans PTCC 5027 after 48 hrs by microplate alamar blue assay2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives.
AID566704Inhibition of human recombinant MMP3 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID397006Antibacterial activity against Salmonella enteritidis PTCC 1091 after 24 hrs by microplate alamar blue assay2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives.
AID566703Inhibition of human recombinant MMP2 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID397005Antibacterial activity against Escherichia coli PTCC 1338 after 24 hrs by microplate alamar blue assay2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives.
AID566705Inhibition of human recombinant MMP8 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID1363739Inhibition of Influenza A (A/California/04/2009) (H1N1) clinical isolate N-terminal truncated PA endonuclease using 5'-FAM/3-TAMRA quencer labeled 17-mer ssDNA-oligo as substrate measured over 45 mins by FRET assay2018Journal of medicinal chemistry, 11-21, Volume: 61, Issue:22
Structure-Activity Relationships in Metal-Binding Pharmacophores for Influenza Endonuclease.
AID566702Inhibition of human recombinant MMP1 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID397008Antibacterial activity against Staphylococcus aureus PTCC 1337 after 24 hrs by microplate alamar blue assay2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives.
AID397010Antibacterial activity against Bacillus subtilis PTCC 1023 after 24 hrs by microplate alamar blue assay2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives.
AID1635903Inhibition of 8-histidine tagged influenza virus H1N1 N-terminal PA endonuclease expressed in Escherichia coli BL21 cells using single-stranded 5'-FAM fluorophore/3'-TAMRA quencher)-labeled 17-mer ssDNA-oligomer substrate measured over 45 mins by FRET ana2016Journal of medicinal chemistry, 07-14, Volume: 59, Issue:13
Fragment-Based Identification of Influenza Endonuclease Inhibitors.
AID397007Antibacterial activity against Pseudomonas aeruginosa PTCC 1074 after 24 hrs by microplate alamar blue assay2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives.
AID566707Inhibition of mouse recombinant iNOS at 1 mM after 40 mins by colorimetric assay2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566706Inhibition of human recombinant MMP9 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID397009Antibacterial activity against Listeria monocytogenes PTCC 1165 after 24 hrs by microplate alamar blue assay2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives.
AID397012Antifungal activity against Aspergillus niger 5021 after 48 hrs by microplate alamar blue assay2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives.
AID24627Compound was tested for their chelating potential (free ligand) determined by distribution coefficient method.1996Journal of medicinal chemistry, Sep-13, Volume: 39, Issue:19
Synthesis, physicochemical properties, and biological evaluation of hydroxypyranones and hydroxypyridinones: novel bidentate ligands for cell-labeling.
AID566699Inhibition of mushroom tyrosinase at 1 mM after 10 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID24630Compound was tested for their chelating potential with gallium-III complex determined by distribution coefficient method.1996Journal of medicinal chemistry, Sep-13, Volume: 39, Issue:19
Synthesis, physicochemical properties, and biological evaluation of hydroxypyranones and hydroxypyridinones: novel bidentate ligands for cell-labeling.
AID1635905Inhibition of 8-histidine tagged influenza virus H1N1 N-terminal PA endonuclease expressed in Echerichia coli BL21 cells at 50 uM using single-stranded 5'-FAM fluorophore/3'-TAMRA quencher)-labeled 17-mer ssDNA-oligomer substrate measured over 45 mins by 2016Journal of medicinal chemistry, 07-14, Volume: 59, Issue:13
Fragment-Based Identification of Influenza Endonuclease Inhibitors.
AID397172Antifungal activity against Aspergillus flavus PTCC 5003 after 48 hrs by microplate alamar blue assay2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives.
AID566701Inhibition of recombinant anthrax lethal factor at 1 mM after 30 mins by fluorescence assay2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID24629Compound was tested for their chelating potential with Iron-III complex determined by distribution coefficient method.1996Journal of medicinal chemistry, Sep-13, Volume: 39, Issue:19
Synthesis, physicochemical properties, and biological evaluation of hydroxypyranones and hydroxypyridinones: novel bidentate ligands for cell-labeling.
AID1635904Inhibition of 8-histidine tagged influenza virus H1N1 N-terminal PA endonuclease expressed in Escherichia coli BL21 cells at 200 uM using single-stranded 5'-FAM fluorophore/3'-TAMRA quencher)-labeled 17-mer ssDNA-oligomer substrate measured over 45 mins b2016Journal of medicinal chemistry, 07-14, Volume: 59, Issue:13
Fragment-Based Identification of Influenza Endonuclease Inhibitors.
AID24628Compound was tested for their chelating potential with Indium-III complex determined by distribution coefficient method.1996Journal of medicinal chemistry, Sep-13, Volume: 39, Issue:19
Synthesis, physicochemical properties, and biological evaluation of hydroxypyranones and hydroxypyridinones: novel bidentate ligands for cell-labeling.
AID566700Inhibition of human recombinant 5-lipoxygenase at 1 mM after 10 mins by fluorescence assay2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's6 (66.67)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]